EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Li... EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erectile dysfunction. It also offers Lactobacillus rhamnosus Beebiotic MAP01, a proprietary strain to support digestive health and vitality. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0005 | 2.12765957447 | 0.0235 | 0.026 | 0.022 | 117189 | 0.02491024 | DE |
| 4 | -0.005 | -17.2413793103 | 0.029 | 0.029 | 0.022 | 229805 | 0.02595387 | DE |
| 12 | 0.001 | 4.34782608696 | 0.023 | 0.032 | 0.017 | 952231 | 0.02630014 | DE |
| 26 | -0.003 | -11.1111111111 | 0.027 | 0.032 | 0.017 | 610442 | 0.02502533 | DE |
| 52 | -0.01 | -29.4117647059 | 0.034 | 0.038 | 0.017 | 573027 | 0.02746792 | DE |
| 156 | 0.023 | 2300 | 0.001 | 0.038 | 0.001 | 1013423 | 0.00973628 | DE |
| 260 | 0.019 | 380 | 0.005 | 0.038 | 0.001 | 3341475 | 0.00369271 | DE |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。